ArticleClinical and translational radiation oncology2018

PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status.

Ben Fulton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.